Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Employment in the psychedelics industry, Non-hallucinogenic psychedelics to advance mental health care, Congress approves defence bill with $10m for psychedelics research
Mapping the effects of ketamine on the brain, Psilocybin analogue shows positive results, Psychedelic therapy programmes launch for burnout and heartbreak.
Short Wave Pharma aims to innovate eating disorder care, Volunteers called to support groundbreaking psychedelic research, Microdosing could help people with ADHD.
How to regulate psychedelics for non-medical use, Groundbreaking trial to assess real-world efficacy of MDMA therapy for PTSD, Canada recommends launch of psychedelic research programme for Veterans.
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.
Subscribe to the Psychedelics Newsletter
Join over 25,000 investors, academics and operators who receive the latest news on the psychedelic science and healthcare industry. Straight to your inbox once a week.